290 related articles for article (PubMed ID: 19027506)
1. Ototoxicity after combined platinum and fractionated radiation in a novel guinea pig model.
Miller MW; Riedel G; Hoistad D; Sutherland C; Juhn SK; Adams GL; Griffin R; Ondrey FG
Am J Otolaryngol; 2009; 30(1):1-7. PubMed ID: 19027506
[TBL] [Abstract][Full Text] [Related]
2. Intratympanic dexamethasone to prevent cisplatin ototoxicity: a guinea pig model.
Murphy D; Daniel SJ
Otolaryngol Head Neck Surg; 2011 Sep; 145(3):452-7. PubMed ID: 21521888
[TBL] [Abstract][Full Text] [Related]
3. cis-platinum ototoxicity in children.
Weatherly RA; Owens JJ; Catlin FI; Mahoney DH
Laryngoscope; 1991 Sep; 101(9):917-24. PubMed ID: 1886439
[TBL] [Abstract][Full Text] [Related]
4. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
[TBL] [Abstract][Full Text] [Related]
6. Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis.
Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Rasch CR; Schornagel JH; Dreschler WA; Balm AJ
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1320-5. PubMed ID: 17418969
[TBL] [Abstract][Full Text] [Related]
7. Decreased hearing after combined modality therapy for head and neck cancer.
Pearson SE; Meyer AC; Adams GL; Ondrey FG
Am J Otolaryngol; 2006; 27(2):76-80. PubMed ID: 16500467
[TBL] [Abstract][Full Text] [Related]
8. Effect of high-dose cisplatin on auditory brainstem responses and otoacoustic emissions in laboratory animals.
Sockalingam R; Freeman S; Cherny TL; Sohmer H
Am J Otol; 2000 Jul; 21(4):521-7. PubMed ID: 10912698
[TBL] [Abstract][Full Text] [Related]
9. Brain-derived nerve growth factor in the treatment of sensorineural hearing loss.
Meen E; Blakley B; Quddusi T
Laryngoscope; 2009 Aug; 119(8):1590-3. PubMed ID: 19479743
[TBL] [Abstract][Full Text] [Related]
10. Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer.
Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Schornagel JH; Dreschler WA; Rasch CR; Balm AJ
J Clin Oncol; 2007 Aug; 25(24):3759-65. PubMed ID: 17704425
[TBL] [Abstract][Full Text] [Related]
11. Correlation of increased activities of Na+, K+-ATPase and Ca2+-ATPase with the reversal of cisplatin ototoxicity induced by D-methionine in guinea pigs.
Cheng PW; Liu SH; Hsu CJ; Lin-Shiau SY
Hear Res; 2005 Jul; 205(1-2):102-9. PubMed ID: 15953519
[TBL] [Abstract][Full Text] [Related]
12. Ototoxicity, nephrotoxicity and pharmacokinetics of cisplatin and its monohydrated complex in the guinea pig.
Ekborn A; Lindberg A; Laurell G; Wallin I; Eksborg S; Ehrsson H
Cancer Chemother Pharmacol; 2003 Jan; 51(1):36-42. PubMed ID: 12497204
[TBL] [Abstract][Full Text] [Related]
13. cis-platinum ototoxicity in children.
Pasic TR; Dobie RA
Laryngoscope; 1991 Sep; 101(9):985-91. PubMed ID: 1886448
[TBL] [Abstract][Full Text] [Related]
14. The effect of radiotherapy on gentamicin ototoxicity: an animal model.
Bezdjian A; Mujica-Mota MA; Devic S; Daniel SJ
Otolaryngol Head Neck Surg; 2015 Jun; 152(6):1094-101. PubMed ID: 25779470
[TBL] [Abstract][Full Text] [Related]
15. High-dose Cisplatin with amifostine: ototoxicity and pharmacokinetics.
Ekborn A; Hansson J; Ehrsson H; Eksborg S; Wallin I; Wagenius G; Laurell G
Laryngoscope; 2004 Sep; 114(9):1660-7. PubMed ID: 15475801
[TBL] [Abstract][Full Text] [Related]
16. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
Cooper LB; Chan DK; Roediger FC; Shaffer BR; Fraser JF; Musatov S; Selesnick SH; Kaplitt MG
Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
[TBL] [Abstract][Full Text] [Related]
17. Differences in Ototoxicity across Species.
Blakley BW; Hochman J; Wellman M; Gooi A; Hussain AE
J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):700-3. PubMed ID: 19128679
[TBL] [Abstract][Full Text] [Related]
18. Ototoxic protection of sodium thiosulfate: daily vs constant infusion.
Stocks RM; Gould HJ; Bush AJ; Dudney BW; Pousson M; Thompson JW
Otolaryngol Head Neck Surg; 2004 Jul; 131(1):115-9. PubMed ID: 15243567
[TBL] [Abstract][Full Text] [Related]
19. [Reduced nutritional status enhances ototoxicity].
Lautermann J; Schacht J
Laryngorhinootologie; 1995 Dec; 74(12):724-7. PubMed ID: 8579670
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of cisplatin-induced ototoxicity by fosfomycin.
Schweitzer VG; Dolan DF; Abrams GE; Davidson T; Snyder R
Laryngoscope; 1986 Sep; 96(9 Pt 1):948-58. PubMed ID: 3747696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
